2m 2m 2m 2m 2m 2m 2m
Axsome Therapeut (AXSM)
NASDAQ
$178.50-$0.75 (-0.42%)
Price as of Oct 02, 2026 7:30 PM EDT- $9.5BMarket Cap
- 49.00%1-Year Change
- BiotechnologyIndustry
Axsome Therapeut (AXSM)
$178.50-$0.75 (-0.42%)
AXSM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $179.25 | ||
Change | -$2.82 (-1.55%) | ||
Open | $182.55 | ||
High | $182.55 | ||
Low | $175.46 | ||
Previous Close | $182.07 | ||
Volume | 982,727 | ||
30-Day Average Volume | 710,123 | ||
1-Week Change | -8.12% | ||
1-Month Change | -14.61% | ||
1-Year Change | 49.00% | ||
3-Year Change | 168.14% | ||
5-Year Change | 422.90% | ||
Fundamentals | |||
Shares Outstanding | 52.4M | ||
Total Assets | $761.4M | ||
Market Cap | $9.5B | ||
Enterprise Value | $9.4B | ||
Period: QTR TTM FY | |||
Revenue | $216.4M | ||
Net Income | -$51.3M | ||
Free Cash Flow | -$33.4M | ||
EBIT | -$48.0M | ||
EBITDA | -$46.4M | ||
Net Working Capital | $196.1M | ||
EPS | -$0.99 | ||
Enterprise Value/EBITDA | -203 | ||
Enterprise Value/Revenue | 43 | ||
P/B | 114 | ||
P/E | -184 | ||
PEG | -9 | ||
Price/Free Cash Flow | -286 | ||
Price/Operating Cash Flow | -289 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue